|
|
|
|
|
Renal protective effect and its related mechanisms of elevated abdominal perfusion pressure treatment in acute kidney injury model caused by intra-abdominal hypertension |
Zheng Yue, Ma Wen-liang, Jiang Yi-jia, Huang Li-feng, Sui Feng, Li Wen Xiong |
SICU, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China |
|
|
Abstract Objective To evaluate the renal protective effect of targeted abdominal perfusion pressure (APP) treatment in intra-abdominal hypertension (IAH) and further investigate its related mechanisms. Methods Twelve healthy pigs were randomly divided into experimental and control group, each had 6 pigs. All animals were collected urine output per hour, continuously monitored mean arterial pressure (MAP) and renal cortical perfusion using laser Dopple perfusion imaging(LDPI) after anesthesia. IAH models were established by intraperitoneally injecting carbon dioxide in all animals, the baseline MAP, intra-abdominal pressure (IAP) and APP were obtained before IAH models established. In both groups, IAP was raised gradually from baseline to 10 mm Hg, 15 mm Hg, 20 mm Hg and 25 mm Hg. In control group, IAP was maintained at 25 mm Hg for 8 hours without any other interventions. In experimental group, the animals were intravenously given with norepinephrine in order to get a target level of APP equal to its baseline values after 15 minutes of the onset of 25 mm Hg IAP. Changes of renal cortical perfusion, serum creatinine, TNF-α, IL-6 and urine IL-18 with the alteration of IAP in both groups were explored. Animals were then sacrificed for renal histopathology after 8 hours of the onset of 25 mm Hg IAP. Results With the increase of IAP, renal cortical perfusion in both groups was significantly decreased (P<0.05). Compared to its baseline, SCr and urinary IL-18 were significantly increased after the maintenance of IAP at 25 mm Hg for 8 hours in control group (P<0.05). And, the level of serum TNF-α and IL-6 also increased significantly (P<0.05). In experimental group, which utilized a strategy of elevated APP, significant improvement of the renal cortical perfusion was observed (P<0.05). SCr and urinary IL-18 were significantly decreased(P<0.05), but TNF-α, IL-6 did not changed significantly(P>0.05). Renal histopathological examination illustrated edema of glomerulus and tubules in specimens of both groups. Conclusion Maintaining IAP of 25 mm Hg for 8 hours can successfully make the model of AKI. The elevated APP treatment may have a renal protective function within the first 8 hours of IAH by improving renal cortical perfusion rather than affecting systemic inflammatory response.
|
Received: 09 September 2017
|
Corresponding Authors:
Sui Feng, E-mail:sicusuifeng@163.com
|
|
|
|
[1]Malbrain ML, Chiumello D, Pelosi P, et al. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study[J]. Intensive Care Med, 2004, 30(5):822-829.
[2]王昱, 陶琨, 郁水华, 等. 连续性血液净化治疗脓毒症合并腹腔高压的疗效观察[J]. 中华危重病急救医学, 2015, 27(5):392-394.[3]De Waele JJ, De Laet I. Intra-abdominal hypertension and the effect on renal function[J]. Acta Clin Belg, 2007, 62(Suppl 2):371-374.
[4]Kim IB, Prowle J, Baldwin I, et al. Incidence, risk factors and outcome associations of intra-abdominal hypertension in critically ill patients[J]. Anaesth Intensive Care, 2012, 40(1):79-89.
[5]Doty JM, Saggi BH, Blocher CR, et al. Effects of increased renal parenchymal pressure on renal function[J]. J Trauma, 2000, 48(5):874-877.
[6]Malbrain ML, De Laet IE, De Waele JJ, et al. Intra-abdominal hypertension: definitions, monitoring, interpretation and management[J]. Best Pract Res Clin Anaesthesiol, 2013, 27(2):249-270.
[7]Vidal MG, Ruiz Weisser J, Gonzalez F, et al. Incidence and clinical effects of intra-abdominal hypertension in critically ill patients[J]. Crit Care Med, 2008, 36(6):1823-1831.
[8]Mohan R, Hui-Chou HG, Wang HD, et al. Physiologic changes with abdominal wall reconstruction in a porcine abdominal compartment syndrome model[J]. Hernia, 2015, 19(2):313-321.
[9]Peng ZY, Critchley LA, Joynt GM, et al. Effects of norepinephrine during intra-abdominal hypertension on renal blood flow in bacteremic dogs[J]. Crit Care Med, 2008, 36(3):834-841.
[10]Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome[J]. Intensive Care Med, 2013, 39(7):1190-1206.
[11]Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome[J]. J Am Soc Nephrol, 2011, 22(4):615-621.
[12]Toens C, Schachtrupp A, Hoer J, et al. A porcine model of the abdominal compartment syndrome[J]. Shock, 2002, 18(4):316-321.
[13]隋峰, 李文雄, 郑悦, 等. 目标性腹腔灌注压治疗在腹腔高压状态下对肾保护的实验研究[J]. 国际外科学杂志, 2013, 40(2):77-81,封3.
[14]Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup[J]. Nat Rev Nephrol, 2017, 13(4):241-257.
[15]Sallisalmi M, Oksala N, Pettila V, et al. Evaluation of sublingual microcirculatory blood flow in the critically ill[J]. Acta Anaesthesiol Scand, 2012, 56(3):298-306.
[16]Sui F, Zheng Y, Li WX, et al. Renal circulation and microcirculation during intra-abdominal hypertension in a porcine model[J]. Eur Rev Med Pharmacol Sci, 2016, 20(3):452-461.
[17]孙薇, 罗高兴, 吴军. 激光多普勒技术在烧伤创面深度及愈合时间评价中的应用进展[J]. 中华烧伤杂志, 2011, 27(4):287-290.
[18]隋峰, 郑悦, 马文良, 等. 腹腔高压致肾脏和全身微循环变化的实验研究[J]. 中国急救医学, 2017, 37(1):81-86.
[19]Rezende-Neto JB, Moore EE, Melo de Andrade MV, et al. Systemic inflammatory response secondary to abdominal compartment syndrome: stage for multiple organ failure[J]. J Trauma, 2002, 53(6):1121-1128. |
|
|
|